<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 65 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page64.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=65">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 65 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 65</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=65"><img src="../thumb/65.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>34 / 2020-04                                                         Central Nervous System - 1.6
   (S3) INJ, [P/S] B1624. 50 mg/ml.  EPIKEPP, Cipla [P/S]     placenta, elderly, ren.insuffic., monit. weight gain as risk fact.for poly-
   Phenytoin Na                 Levetiracetam                 cyst.ovary syndr., monother.recomm.in childr.und.3 yrs., avoid concom.
   Indications: Stat.epilept.of grand mal type., prevent. & treatm.of   Indications: Adjunct.ther.in partial onset seiz. with/without second.  salicylates in childr.und.3 yrs., bld.tests bef. surg/with spontan.bruis./
   seiz.dur./aft.neurosurg., cert. arrhythm.esp.digital.induc.  generalisat.in adults & childr. over 16 yrs.with epilep.  bleed., SLE, suspect. urea cycl.enzymat.defic., diabet.
   723576-011: 5 ml, 10, R3 916,64  (S3) TABS, 43/2.5/1164, 1165, 1166.  Drug interactions: Eff.of other psychotrop. potent., rais.phenobarb.
   Dosage: Individ. Optim.contr.often achiev.with ser. lev. betw. 10-  721701-001: 250 mg, 60, R125,05  plasma conc., primidone plasma lev.incr., phenytoin tot.plasma conc.
   20 mcg/ml. Infus.rate not to exceed 50 mg/min. in adults & 1-3 mg/  721702-001: 500 mg, 60, R250,16  decr.& phenytoin free form incr., tox.eff.of carbamazep. potent., me-
   kg/min in neonates.          721703-001: 750 mg, 60, R381,19  tabol.of lamotrig.reduc., zidovud. plasma conc.rais., anti-epilept.eff.
   Status epilept.& neurosurg.(for prophylax.& seiz.treatm.).   Dosage: Admin.dly.dos.in 2 equal div.dos.  antagon.by antidepress. & neurolept., ser.conc.decr.by anti-epilept.
   Adults: Load.dos: 10-15 mg/kg bm IV (rate &lt;50 mg/min.) follow.by   Adj.therapy: Adults & adolesc.old.than 16 yrs: Therapeut.dos.of   with enzyme induc.eff., incr.ser.conc.with felbamate, mefloquine incr.
   maint.dos (pref. oral) of 300-400 mg/day with max.of 600 mg dly.   500 mg 2xdly start.on 1  day of treatm. Dly.dos.may be incr.up to 1 500   valproic acid metabol. & has convuls.eff., chloroquine may low.seiz.
                                          st
   Childr: Load.dos: 10-20 mg/kg bm IV at rate not exceed. 1-3 mg/kg/  mg 2xdly. depend.upon clinic.respons.& tol. Dos.changes can be made   threshold, valproate free ser.lev.incr.by high.prot. bound agents, an-
   min. Maint.dos.(pref. oral): 4-8 mg/kg/day admin.in div.dos.  in 500 mg 2xdly increm./decrem.every 2-4 wks. Max.dly dos: 3000 mg.  ticoag.eff.of vit.K depend.fact. anticoags.incr., cimetid.& erythromyc.
   Card.arrhythm: Init. 3,5-5 mg/kg bm IV & at a unif. rate not ex-  Contraindications: Pyrrolidone derivat. hypersens., pregn., lactat.,   poss. incr. ser. lev., valproate bld.lev.decr.by carbapenem antibiot.
   ceed.1 ml (50 mg)/min. Rep.once if necess., slow admin.of 30-50   insuffic data in childr. und.16 yrs.
   mg./min is pref.             Side effects: Infect., bld.dyscras., pancreatit., anorex., psych.disords.  EPILIZINE, Winthrop [P/S]
   Contraindications: Porphyr., pregn.unless contin. use consid.es-  incl.depersonalisat./ depress/aggres. & psychot.disords., dizzin., head-  Sodium valproate
   sent., lactat., hydantoin prod. hypersens., recurr.rash on reinstitut.of   ache, somnol., atax., amnes., emotion. labil., vertigo, asthen., paraes-  Indications: Gen.epilep.partic.with absence/ myoclon./ ton.-clon./
   treatm. Inj. only: Sinus bradycard., SA block, 2nd & 3rd degree AV-  thes., hostility, nervousn., convuls. insomn., trem., diplop., GI disturbs.,   aton.& mix.seiz., part. epilep.with simple or complex seiz./second.
   block, Adams Stokes syndr.   pharyngit., rhinit., sinusit., cough., skin rash, alopec., accid.injury, fatig.  gen. seiz & specif.syndr.eg.West & Lennox Gastaut, treatm.& prev.
   Side effects: Bld.dyscras., lymphadenopathy incl. benign lymph   Warnings and special precautions: Grad. withdr./tfd.to other anti-  of mania assoc.with bipol.disords.
   node hyperplas., pseudolymphoma, lymphoma, Hodgkin’s dis., pan-  epilept.ther., ren.impairm. esp.elderly, indiv.dos.accord.to ren.funct.in   (S3) CR TABS, A39/2.5/0038, 0039, 0040
   cytopen.with/-out bone marr.suppress., hypersens. syndr.incl. anaph-  ren. impairm.(ref.to prod.lit.), monit.ren.funct.in sev.imp.hepat.funct.  718274-001: 200 mg, 100, R342,96
   pylax., periarterit.nodosa, skin reacts. incl. lupus erythemat./Stev.  Drug interactions: Meds excret.by act.tubul. secret.may reduc.ren.   718275-001: 300 mg, 100, R514,18
   Johns.& tox.epiderm. necrolys., trans.nervousn., insom., ment.con-  clear. of metabolite, food reduc.rate of absorpt.sligthly  718276-001: 500 mg, 100, R851,02
   fus., dizzin., nystagm., paraesthes., atax., decr.co-ordinat., headache,   Dosage: Take with/aft.food. Do not crush or chew tabs. Admin.once/
   somnol., phenytoin induc. dyskines., sensor.periph.neuropathy, slurr.  EPILIM, Sanofi-Aventis [P/S]  twice dly. Dly.dos.vary accord. to age & body weight. Optimum dos.
   speech, taste pervers., N&V, constip., gingiv.hyperplas., liv.damage,   Na valproate  main.determ. by seiz.control.
   tox.hepatit., motor twitch., coarsen.of fac. features, SLE, Peyronie’s   Indications: Gen.epilep.partic.with absence/ myoclon./ ton.-clon./  Epilepsy: Adults: Start 600 mg/day where applic in div.dos.incr.
   dis., bone fract., osteomalac., rickets, osteoporos., hypocalcaem.,   aton.& mix.patt.seiz., part. epilep.with simple or complex seiz./sec-  by 200 mg/day at 3 day interv.until contr.achiev.gen.betw. 1 000-
   hypophosphataem., decr.levels of vit D metabolites, hyperglycaem.,   ond.gen. seiz & specif.syndr.eg.West & Lennox Gastaut. CR tabs   2 000 mg/day. If not stabil.aft.2 wks.may incr.to max.of 2 500 mg/
   neonat.life. threaten. haemorrh.within 24 hrs.of birth, Inj: Alterat.in   also for: Treatm.& prev.of mania assoc.with bipol.disords. IV ther:   day or one other anti-epilept.add.at low dos. Childr. over 20 kg: Init.
   card. & resp.funct., hypotens.with rapid IV admin., sev. cardiotox.   Where oral ther.temp.not poss.  400 mg/day irrespect.of mass.in div.dos.with spaced incr.until contr.
   reacts., loc. reacts.at inj.site.  (S3) SUGAR-FREE LIQ, [P/S] J/2.5/148.  achiev., usual. betw.20-30 mg/kg bm/day. If not stabil.may incr.to
   Warnings and special precautions: Not effect. for petit mal   780545-001: 200 mg/5 ml, 300 ml, R339,37  35 mg/ kg bm/day. Childr.und.20 kg: 20 mg/kg bm/day. May be
   seiz., not indic.for seiz.due to hypoglycaem./ other metabol.caus.  (S3) CRUSH.TABS, [P/S] 27/5.2/0500  incr.in sev.cases where clinic. chem. & haematolog.paramet.may
   theref. perform. appropr.diagnost.proced., abrupt.withdr.may incr.   821578-006: 100 mg, 100, R336,76  be monit.in dos. above 40 mg/kg/day.
   freq.& precipitate status epilepticus, where rapid substit.reqd.  (S3) CR TABS, [P/S] 27/2.5/0322, Y/2.5/286, 27/2.5/0323.  Treatm.& prev.of mania assoc.with bipol. disords: Recomm.
   due to hypersens.react.use alt.ther.not belong.to hydantoin class,   Na valproate & valproic acid equiv.to Na Valproate  init.dos: 1 000 mg/day. Incr.as rapid.as poss.to achiev.low.therapeut.
   some indiv.may metabol. phenytoin slowly, suic.ideat.& behav.   818666-005: 200 mg, 100, R468,92  dos.produc. desir.clinic.eff. Adjust accord.to indiv.clinic. respons. Est.
   report., potent.fatal multi organ anticonvuls. hypersens. syndr   818674-008: 300 mg, 100, R653,96  prophylact.treatm.indiv.with low. effect. dos.
   (AHS) report.reflect.by drug rash with eosinophil.& syst.sympts.,   818682-019: 500 mg, 100, R1 163,60  (S3) POWD.FOR IV INJ, [P/S] A40/2.5/0699, A40/34/0781
   high.AHS risk in black pts./person.or fam.hist./immune-suppress.   Dosage: Take with/aft.food. Do not dil.sugar free liq. Do not crush   Indications: When oral ther.tempor.not poss.in gen.epilep.partic.
   pts., discontin.& prov.appropr.supp.meas.if AHS diagnos., seek   or chew CR.tabs. Admin.CR tabs. once /twice dly. Dly.dos.vary ac-  with absence/ myoclon./ ton.-clon./aton.& mix.seiz., part.epilep.with
   alt.ther.if skin rash of sev.nature, confus. states/cerebell.dysfunct.  cord.to age & body weight.  simple or complex seiz./second.gen. seiz & specif.syndr. eg.West &
                          st
   may aris.from above optim.ser.lev.theref.investig.at 1  sign of ac.   Adults: Start 600 mg/day div.dos.incr.by 200 mg/ day at 3 day interv.  Lennox Gastaut.
   toxic., extend.follow-up observat.of all lymphadenopathy with al-  until contr.achiev.gen.betw. 1 000-2 000 mg/day. If not stabil.aft.2 wks.  718277-001: 400 mg, 1 vial & solv. R244,05
   ternat.anticonvuls. ther. recomm., folic acid ther.to correct anaem.  may incr.to max.of 2 500 mg/ day. Childr.over 20 kg: Init. 400 mg/   Dosage: Adults: Admin.by direct slow IV inj./ infus.using sep.IV line
   may decr. seiz.control, discont.immed.& do not re-admin in cases   day irrespect.of mass.in div.dos.with spaced incr.until contr.achiev.,   in NaCl/dextr.5%/ dextr. NaCl. Indiv.accord.to clinic.respons. Pts.al-
   of ac.hepatotox., avoid meds. assoc.with Stev.Johns & tox.epiderm.  usual.betw.20-30 mg/kg bm/day. If not stabil.may incr.to 35 mg/ kg   ready satisfact.treat.may be contin.on their curr.dos./ repeat.infus.
   necrolys in HLA-B*1502 posit.pts., hyperglycaem.from the inhibit.  bm/day. Childr.und. 20 kg: 20 mg/kg bm/day. May be incr.in sev.  Other pts.may be given a slow IV inj.over 3-5 min.usual.400-800 mg
   eff.on insul.release, rais.ser.gluc.in diabet., bone min.metabol.in-  cases where clinic.chem.& haematolog.paramet.may be monit.in   depen.on body weight (up to 10 mg/kg) follow.by contin./rep. infus.
   direct.affect.by incr.Vit.D3 metabol. with incr.risk of osteomalac/  dos.above 40 mg/ kg/day.  up to a max.of 2500 mg/day. Tfd.to oral ther.as soon as poss. Childr:
   bone fract & osteoporos. with chron.treatm., use dur.pregn./ poss.  CR Tabs: Treatm.& prev.of mania assoc.with bipol. disords:   Usual range: 20-30 mg/kg/day admin.as above. Monit.clinic.chem.&
   pregn.due to assoc.teratogenic when admin. dur.pregn.& high. in-  Recomm.init.dos: 1 000 mg/day. Incr.as rapid.as poss.to achiev.low.  haematolog.paramet.with dos.above 40 mg/kg/ day. Valproate plas-
   cid.of congenit.abnormalit., malign. incl.neuroblastoma report.in   therapeut.dos. produc.desir.clinic.eff. Adjust accord.to indiv. clinic.   ma conc.assoc.with therapeut. eff.approx.30-100 mcg/ml. Optim.dos.
   childr.of mothers who recd.dur.pregn., incr.seiz.freq. dur.pregn.as a   respons. Est.prophylact.treatm.indiv.with low. effect.dos.  main. determ.by seiz.control.
   result of alt.absorpt./metabol., incr. risk of neonat.haemorrh.& ma-  (S3) INJ, [P/S] Y/2.5/43, Y/34/156.  Contra-indications: Pregn.& lactat., act.liv.dis., hepat. dysfunct.
   tern.bleed.dur.deliv. Inj.also: Purple glove syndr.(oed./discolourat.&   Na Valproate  hist.esp.drug relat., hepat.porphyr.
   pain dist.to inj.site),IV admin.through large gauge catheter should   821551-019: 400 mg, 1 vial &dil. R468,14  Side-effects: Sev.liv.damage & pancreatit.(with fatalit.), GI disturbs.,
   be preced. by saline flush.& follow. by sterile saline through the   Dosage: Adults: Admin.by direct slow IV inj./ infus.using sep.IV   confus., coma, revers. dement./cerebr.atrophy/revers.Parkinson.,
   same needle/ IV cath.to reduc.loc.vein.irrit., IM route not recomm.   line in NaCl/dextr.5%/ dextr. NaCl. Pts.already satisfact.treat.may be   trem., somnol., hyperammonaem.also assoc.with neurologic. sympts.,
   as ser.lev.in therap.range not readily/ predictab. achiev.with this   contin.on their curr.dos./repeat.infus. Other pts.may be given a slow   bld.dyscras., thrombocytopen., incr. bleed.time., skin & subcutan.tiss.
   route, avoid.contin. infus., admin.as addit.to IV infus.not recomm.  IV inj.over 3-5 min.usual.400-800 mg depen. on body weight (up to   disords.incl. tox.epiderm.necrolys./Stev.Johns.syndr.& erythema mul-
   due to lack of solubilit./result.precipitat., hypotens., sev. myocard.  10 mg/kg) follow.by contin./ rep.infus.up to a max.of 2500 mg/day.   tiforme, hair loss, amenorrh., irreg. periods, vasculit., hear.loss, revers.
   insuffic., grad.withdr./substitut., admin. vit.K to mother dur.deliv.&   Tfd.to oral Epilim as soon as poss. Childr: Usual range: 20-30 mg/  Fanconi’s syndr., allerg. reacts., non-sev.periph.oed., weight incr.
   neonate immed. aft. deliv.to prev./correct.poss.coagul.defects, ex-  kg/day admin.as above.  Special precautions: Pts.at high risk of liv. dysfunct. esp.with multipl.
   cret. in breast milk, imp.liv.funct., elderly, sev.ill, hepat. dis., exac-  Combin.ther: Taper other anticonvuls.slow.init. Epilim ther.grad.  anticonvuls.ther.are infts. & childr.und.3 yrs.with sev.seiz.disords. par-
   erb.porphyr., poss.vit.D supplem. with long-term ther., advis.pt.to   with target dos.reach.aft.approx.2 wks. If used in conjunct.with an-  tic. with brain damage/met.retard.&./congenit. metabol.or degenerat.
   report.developm.of skin rash, stagger dos.of Ca.contain.preps.incl.   ticonvuls.which induc.liv.enzyme activ.(eg phenytoin, phenobarbital   dis., monit.clinic.sympts.& liv.funct.tests incl.prothromb.rate dur.1st 6
   antacids which may interfer with absorpt., TCA’s may precipit.seiz.  & carbamazepine) dos.may need to be incr.by 5-10 mg/kg/day. Once   mnths. for early signs of hepat.fail., discont.concom. salicylates as
   in suscept.indiv., enteral feed. preps. may low.plasma lev., 8% drug   known enzyme induc.have been withdr.it may be poss.to maint seiz.  precaut., hepat.fail with pancreatit. incr.fatal outcome risk, sev.liv.
   content incr. in free acid form over that of Na.salt theref. poss. dos.  contr.on a reduc.Epilim dos. Reduc.dos.of concom. barbitur. esp.if   damage and pancreatit. risk decr.with age, discont.ther.with pancre-
   adjustm./monit.necess. if switch.formulat., lact. intol., pts.with hist.  sedat.(partic.in childr.) is observ.  atit., concom.anticoags./prod.with anticoag. propert., do not discont.
   of ren./liv.dis.should not rec.oral load.regim.  Contra-indications: Avoid in pregn.& lactat., act.liv.dis., hepat.dys-  anti-epilept.ther.sudd.in event of pregn.as breakthrough seiz.with ser.
   Drug interactions: Phenytoin ser.lev.incr.by: Ac. alcoh.intake/azapro-  funct.hist.esp.if drug relat., hepat. porphyr.  effs. poss., incr.incid.of congenit. abnormalit.report.with anti-epilept.
   pazone/phenylbutazone/salicylates, halothane/, chloramphen/eryth-  Side-effects: Liv.dysfunct.(incl.hepat.fail.with fatalit.), pancreatit.,   treatm., sod.valproate teratogen.in anim., folate supplementat.poss.
   romycin/ isoniazid/ sulphonamides/felbamate/ succinimides/ ampho-  incr.foet.malformat./develop. delay in childr.born to epilept.mothers,   appropr.bef. plann. pregn.to minim.neur.tube defects risk, monother.
   tericin B/fluconazole/ ketoconazole/ miconazole/itraconazole/ fluo-  haemorrhag. syndr.in neonates, GI disturbs., confus., coma, revers.  at minim.effect.dly dos.admin.in sev.div.dos.over day & prolong.rel.
   rouracil/ chlordiazepoxide/ diazepam/ disulfiram/ methylphenidate/   dement./cerebr.atrophy/ Parkinson., trem., somnol., hyperammon-  formulat.pref.in pregn.,cross.placenta, pres.in breast milk, haemor-
   trazodone/ viloxazine/ amiodarone/ dicumarol/ diltiazem/ nifedipine/  aem. also assoc. with neurologic. sympts., bld.dyscras., incr. bleed.   rhag.syndr.in neonates born to mothers tak.sod.valproate, elderly,
   ticlopidine/ cimetid./oestrog./ tolbutamide/ omeprazole/ fluoxetine/  time., skin & subcutan.tiss.disords.incl.Stev. Johns.syndr., hair loss,   ren.insuffic., monit. weight gain as risk fact.for polycyst.ovary syndr.,
   fluvoxamine/ sertraline.     amenorrh., irreg.periods, vasculit., hear.loss, revers.Fanconi’s syndr.,   monother.recomm.in childr.und.3 yrs., avoid concom. salicylates in
   Phenytoin ser.lev.decr.by: Chron.alcoh.abuse/ rifampin/ ciprofloxacin/  allerg. reacts., non-sev.periph.oed., weight incr., oed., thrombocy-  childr.und.3 yrs., bld.tests bef. surg/with spontan.bruis./bleed., SLE,
   vigabatrin/sucralfate/ theophylline/ reserpine/antineoplast.agents/   topen., atax., sedat., lethargy & aggress., hyperactiv., behav.dete-  suspect. urea cycl.enzymat.defic., false posit.urine read.in poss.diabet.
   diazoxide/ molindone HCl & nelfinavir  riorat., incr. appet., min.gastr.irrit., trans.hair loss, signs of immune   Drug interactions: Effs.of other psychotrop. potent., rais.phenobarb.
   Phenytoin ser.lev.incr./decr.by: Ciprofloxacin/ carbamazepine/ phe-  disord., gynaecomast.  plasma conc., primidone plasma lev.incr., phenytoin tot.plasma conc.
   nobarb., Na-valproate, valproic acid/ chlordiazepoxide/diazepam.  Special precautions: Pts.at high risk of liv. dysfunct. esp.with   decr.& phenytoin free form incr., tox.eff.of carbamazep. potent., me-
   Bld.lev./effs.alt.by phenytoin: Doxycycline/ praziquantel/ rifampin/  multipl.anticonvuls.ther.are infts. & childr.und.3 yrs.with sev.seiz.  tabol.of lamotrig.reduc., zidovud. plasma conc.rais., anti-epilept.eff.
   tetracycl./lamotrigine/ azoles/ teniposide/ theophylline/digitoxin/   disords. partic. with brain damage/ment.retard.&./ congenit. me-  antagon.by antidepress. & neurolept.which low.seiz.threshold, ser.
   nicardipine/ nimodipine/quinidine/verapamil/ corticoster./ coumar.  tabol.or degenerat.dis., monit.clinic. sympts. & liv.funct.tests incl.  conc.decr.by anti-epilept.with enzyme induc. eff., incr.ser.conc.with
   anticoags./cyclosporine/ furosemide/ oestrog./OC’s/diazoxide/  prothromb.time dur.1st 6 mnths. for early signs of hepat.fail., also   felbamate, mefloquine incr. valproic acid metabol.& has convuls.eff.,
   alcuronium/ pancuronium/ vecuronium/methadone/ chlorpropa-  discont. concom. salicylates if lab.abnorm.detect., do not discont.   chloroquine may low.seiz.threshold, valproate free ser.lev.incr.by high.
   mide/ glyburide/tolbutamide/clozapine/ paroxetine/sertraline/Vit.D.  anti-epilept.ther.sudd.in event of pregn.as breakthrough seiz.with   prot.bound agents (aspirin), anticoag. eff.of vit.K depend.fact. anti-
   Zidovudine clear.decr., effect of phenytoin on carbamazepine/ phe-  ser.effs.poss., careful. evaluat. dur.pregn., consid.folate supplem.dur.   coags.incr., cimetid.& erythromyc.poss.incr.ser.lev., valproate bld.lev.
   norbarbital/ valproic acid/ Na valproate unpredict.  pregn. to poss.minim.neur.tube defect.risk, pres.in breast milk, cross.  decr.by carbapenem antibiot.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page64.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page60.html">60</a>&nbsp;&nbsp;&nbsp;<a href="page61.html">61</a>&nbsp;&nbsp;&nbsp;<a href="page62.html">62</a>&nbsp;&nbsp;&nbsp;<a href="page63.html">63</a>&nbsp;&nbsp;&nbsp;<a href="page64.html">64</a>&nbsp;&nbsp;&nbsp;<a href="page65.html">65</a>&nbsp;&nbsp;&nbsp;<a href="page66.html">66</a>&nbsp;&nbsp;&nbsp;<a href="page67.html">67</a>&nbsp;&nbsp;&nbsp;<a href="page68.html">68</a>&nbsp;&nbsp;&nbsp;<a href="page69.html">69</a>&nbsp;&nbsp;&nbsp;<a href="page70.html">70</a>
             </td>
             <td width="35%"><a href="page66.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page66.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
